knowledge -WSS

knowledge

author：comprehensive 2025-08-12 08:30:21 - browse：6367

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

hotspot

focus

WSS

In early work, researchers turn to CRISPR to treat Alzheimer's

Gilgo Beach: Police identify another victim in serial killing investigation

Custom gene therapy hints at new path for rare disease treatments

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Medicare has a new plan to address drug shortages

'Ancient DNA,' 23andMe reveal African American ancestries

focus

knowledge

focus

Medical leaders decry Supreme Court decision on affirmative action

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

In Memoriam: Notable people who died in 2023

Doctors find melanoma drugs effective against rare brain cancer

Alkermes shareholders re

OTC birth control: A brief history of over the counter pill design

Continuity nursing helped my family in our darkest PICU moments

In early work, researchers turn to CRISPR to treat Alzheimer's

Medical records are filled with copy

Key House panel plots a new health care package

focus

Gilgo Beach: Police identify another victim in serial killing investigation

Why hospitals are withdrawing from US News rankings

Why hospitals are withdrawing from US News rankings

Stem cell clinics for heart failure: buyer be wary

White House drug shortage group privately met with industry

How dance can help nurses traumatized by Covid

hotspot

focus

explore

focus